TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23848078

Group type: EXPERIMENTAL
Intervention: Strength training (S; n = 24)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Endurance training (E; n = 26)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combined strength and endurance training (SE; n = 24)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Recommendations of physical activity (PA; n = 22)
Number of subjects: 96
Study: 21730344

Group type: EXPERIMENTAL
Intervention: Web-based educational modules for vision education
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (chlamydia and blood pressure education)
Number of subjects: 107
Study: 19700198

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes without AMD
Number of subjects: 4757

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with mild AMD
Number of subjects: 4757

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with moderate AMD
Number of subjects: 4757

Group type: EXPERIMENTAL
Intervention: Cataract surgery in eyes with advanced AMD
Number of subjects: 4757
Study: 17123987

Group type: EXPERIMENTAL
Intervention: 10 Necator americanus larvae
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 25 Necator americanus larvae
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 50 Necator americanus larvae
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 100 Necator americanus larvae
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All doses
Number of subjects: 10
Study: 15337214

Group type: EXPERIMENTAL
Intervention: Heart failure with preserved EF
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Glomerular filtration rate
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: New York Heart Association functional class III or IV
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 988

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 988
Study: 11235780

Group type: EXPERIMENTAL
Intervention: Forceful saline injections (20 ml) with or without prednisolone acetate (125 mg)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Epidural prednisolone acetate (125 mg) alone
Number of subjects: 47
Study: 9286184

Group type: EXPERIMENTAL
Intervention: Olanzapine (up to 20 mg/day, median exposure 237 days)
Number of subjects: 904

Group type: COMPARATOR
Intervention: Haloperidol (up to 20 mg/day, median exposure 203 days)
Number of subjects: 904
Study: 8420315

Group type: EXPERIMENTAL
Intervention: PROEF diet
Number of subjects: 118

Group type: COMPARATOR
Intervention: Routine postoperative dietary management (control)
Number of subjects: 118
Study: 3764810

Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (5000iu two hours before operation and then twelve hourly for seven days)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Subcutaneous saline (control group)
Number of subjects: 61
Study: 28368953

Group type: EXPERIMENTAL
Intervention: Proprioceptive-coordinative training (P-CT; n = 26)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Regular training (RT; n = 27)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (C; n = 22)
Number of subjects: 53
Study: 28585761

Group type: EXPERIMENTAL
Intervention: Somatic experiencing (SE) therapy, 15 weekly sessions.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Waitlist control group, no intervention during the initial 15 weeks.
Number of subjects: 63
Study: 25575716

Group type: EXPERIMENTAL
Intervention: GlideScope® (GS)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: McGrath® Series 5 (McG)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 72
Study: 23458112

Group type: EXPERIMENTAL
Intervention: Integrative psychodynamic inpatient therapy
Number of subjects: 47
Study: 21975307

Group type: COMPARATOR
Intervention: As-finished (600 grit SiC; control)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Sandblasted
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Etched
Number of subjects: 135
Study: 19448968

Group type: EXPERIMENTAL
Intervention: Indigocarmine chromocolonoscopy (Group A)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Conventional colonoscopy (Group B-1)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Chromocolonoscopy (Group B-2)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Advanced lesions (all groups)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Diminutive polyps (Groups A and B-2)
Number of subjects: 400
Study: 16496492

Group type: EXPERIMENTAL
Intervention: EDTA (35 mg/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: EDTA + AC (50 grams)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (water)
Number of subjects: 8
Study: 14671696

Group type: EXPERIMENTAL
Intervention: Saphenofemoral disconnection under local anesthesia
Number of subjects: 84

Group type: COMPARATOR
Intervention: Enoxaparin on an outpatient basis for 4 weeks
Number of subjects: 84
Study: 11187915

Group type: EXPERIMENTAL
Intervention: DCLSG protocol ALL-6 (1984-1988) with chemotherapeutic CNS prophylaxis (dexamethasone, i.v. medium dose methotrexate, intrathecal triple therapy) for 116 weeks
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: DCLSG protocol ALL-7 (identical to ALL-BFM-86 protocol, cranial irradiation restricted to patients with initial CNS involvement) for 18 months
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Standard risk non-T lineage ALL patients in protocol ALL-6
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Standard risk non-T lineage ALL patients in protocol ALL-7
Number of subjects: 408
Study: 8646873

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate ointment, 0.005%
Number of subjects: 372

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 372
Study: 1995934

Group type: EXPERIMENTAL
Intervention: Proguanil 100 mg daily
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Chlorproguanil 20 mg twice weekly
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo prophylaxis
Number of subjects: 76
Study: 6548940

Group type: EXPERIMENTAL
Intervention: Sucralfate (5 g given in 1-g divided doses)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Ibuprofen (600 mg)
Number of subjects: 9
Study: 30073637

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 51
Study: 29912571

Group type: EXPERIMENTAL
Intervention: PAT+ (Parents as Teachers with additional content on breastfeeding)
Number of subjects: 118

Group type: COMPARATOR
Intervention: PAT (Parents as Teachers)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: PAT+
Number of subjects: 118

Group type: COMPARATOR
Intervention: PAT
Number of subjects: 118
Study: 26314868

Group type: EXPERIMENTAL
Intervention: SOS prevention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 24656947

Group type: EXPERIMENTAL
Intervention: Rare hamburger
Number of subjects: 1046

Group type: COMPARATOR
Intervention: Well-done hamburger
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: All hamburgers (rare, medium rare, medium well-done, well-done)
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Rare hamburgers
Number of subjects: 1046
Study: 22201688

Group type: EXPERIMENTAL
Intervention: Clay pitch surface
Number of subjects: 22

Group type: COMPARATOR
Intervention: Artificial turf pitch surface
Number of subjects: 22
Study: 20608923

Group type: EXPERIMENTAL
Intervention: Rocuronium mixed with sodium bicarbonate 8.4%
Number of subjects: 120

Group type: COMPARATOR
Intervention: Rocuronium mixed with isotonic saline
Number of subjects: 120
Study: 17509350

Group type: EXPERIMENTAL
Intervention: Tolterodine (1 mg twice daily) with behavioral modification
Number of subjects: 72

Group type: COMPARATOR
Intervention: Behavioral modification only
Number of subjects: 72

Group type: COMPARATOR
Intervention: Behavioral modification plus placebo
Number of subjects: 72
Study: 16055817

Group type: EXPERIMENTAL
Intervention: Integrated treatment
Number of subjects: 547

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 547
Study: 12161484

Group type: EXPERIMENTAL
Intervention: raloxifene 60 mg/d
Number of subjects: 7705

Group type: EXPERIMENTAL
Intervention: raloxifene 120 mg/d
Number of subjects: 7705

Group type: EXPERIMENTAL
Intervention: raloxifene 60 mg/d and 120 mg/d
Number of subjects: 7705
Study: 10102544

Group type: EXPERIMENTAL
Intervention: Health promotion program providing social support and psychoeducational intervention with positive reframing psychotherapeutic maneuver
Number of subjects: 28
Study: 8700340

Group type: EXPERIMENTAL
Intervention: Acarbose 300 mg/day for 12 weeks with hypocaloric diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hypocaloric diet only (Control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Acarbose 300 mg/day
Number of subjects: 12
Study: 1810616

Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conservative treatment with long-leg plaster (group B)
Number of subjects: 90
Study: 6622929

Group type: EXPERIMENTAL
Intervention: Prednisolone plus azathioprine 50 mg daily
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Azathioprine 100 mg daily
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Prednisolone (Dutimelan 8 15)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 204
Study: 31858966

Group type: EXPERIMENTAL
Intervention: Enhanced motivational interviewing (MI) with behaviour change techniques (BCTs) delivered in group format
Number of subjects: 1742

Group type: EXPERIMENTAL
Intervention: Enhanced motivational interviewing (MI) with behaviour change techniques (BCTs) delivered in individual format
Number of subjects: 1742

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 1742
Study: 30132529

Group type: EXPERIMENTAL
Intervention: Glucosamine (2 g/day for 16 weeks)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 27916140

Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (2 cans of beer, 660 mL, ∼26 g alcohol)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Alcohol-free beer consumption (control)
Number of subjects: 24
Study: 25076468

Group type: EXPERIMENTAL
Intervention: Artificial pupil contact lens
Number of subjects: 38

Group type: COMPARATOR
Intervention: Contralateral balanced multifocal contact lens combination (CBMCLC)
Number of subjects: 38
Study: 22402677

Group type: EXPERIMENTAL
Intervention: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Knee Outcome Survey activities of daily living subscale (KOS‐ADL)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Lower Extremity Functional Scale (LEFS)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: All three outcome measures (WOMAC, KOS‐ADL, LEFS)
Number of subjects: 168
Study: 19470315

Group type: EXPERIMENTAL
Intervention: Brief strategic family therapy (BSFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 16887281

Group type: EXPERIMENTAL
Intervention: Contingency management plus methadone maintenance
Number of subjects: 690

Group type: COMPARATOR
Intervention: THC nonreporters
Number of subjects: 690
Study: 14977155

Group type: EXPERIMENTAL
Intervention: Team-based curriculum
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Individual counselor meetings
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control
Number of subjects: 3
Study: 10882149

Group type: EXPERIMENTAL
Intervention: Cyclical etidronate therapy
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 107
Study: 9376205

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral skills training HIV risk reduction intervention (4 sessions)
Number of subjects: 81

Group type: COMPARATOR
Intervention: HIV risk education and sensitization control condition (4 sessions)
Number of subjects: 81
Study: 8229487

Group type: EXPERIMENTAL
Intervention: Exosurf Neonatal
Number of subjects: 617

Group type: COMPARATOR
Intervention: Survanta
Number of subjects: 617
Study: 3536258

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 2901181

Group type: EXPERIMENTAL
Intervention: 15 mg once daily of methimazole
Number of subjects: 54

Group type: COMPARATOR
Intervention: 10 mg 3 times daily of methimazole
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study: 31694478

Group type: EXPERIMENTAL
Intervention: Cognitive intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Mindfulness-based intervention
Number of subjects: 72
Study: 30226991

Group type: EXPERIMENTAL
Intervention: CATCH EC intervention
Number of subjects: 365

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 365
Study: 28355359

Group type: EXPERIMENTAL
Intervention: Passive cycle ergometer exercise for 20 minutes at 30 cycles/min
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no therapeutic intervention)
Number of subjects: 19
Study: 25182412

Group type: EXPERIMENTAL
Intervention: Real tVNS (transcutaneous vagus nerve stimulation) administered at left external acoustic meatus for 60 min
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham stimulation at left ear lobe for 60 min
Number of subjects: 10
Study: 23491275

Group type: EXPERIMENTAL
Intervention: Axillary dissection
Number of subjects: 933

Group type: COMPARATOR
Intervention: No axillary dissection
Number of subjects: 933
Study: 21575032

Group type: EXPERIMENTAL
Intervention: 5 μg TTX (given t.i.d.)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: 10 μg TTX (given t.i.d.)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study: 18266654

Group type: EXPERIMENTAL
Intervention: Filtek Z250 at 24 hours
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Filtek Z250 at 6 months
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Charisma at 24 hours
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Charisma at 6 months
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Charisma subsurface hardness at 6 months
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Filtek Z250 subsurface hardness at 6 months
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both composites at 6 months
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Both composites surface roughness
Number of subjects: 2
Study: 16436148

Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge (DBPCFC) after prolonged cow's milk elimination diet
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Accidental ingestion of cow's milk during elimination diet
Number of subjects: 11

Group type: COMPARATOR
Intervention: Prolonged cow's milk elimination diet
Number of subjects: 11
Study: 14499444

Group type: EXPERIMENTAL
Intervention: Topical morphine mouthwash (2 per thousand solution)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Topical morphine mouthwash (1 per thousand solution)
Number of subjects: 32
Study: 10872650

Group type: EXPERIMENTAL
Intervention: 10 mg/kg ibuprofen lysine
Number of subjects: 17
Study: 9195171

Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine 40 ml (200 mg)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine 40 ml (100 mg)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Saline 40 ml
Number of subjects: 131
Study: 1287837

Group type: EXPERIMENTAL
Intervention: Continuous bupivacaine infusion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline infusion (Control) in patients with COAD
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Continuous bupivacaine infusion in patients with COAD
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline infusion (Control) in patients without COAD
Number of subjects: 80
Study: 4040887

Group type: EXPERIMENTAL
Intervention: pafenolol 25 mg
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: pafenolol 50 mg
Number of subjects: 31

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 31
Study: 30262297

Group type: EXPERIMENTAL
Intervention: Long-distance runners (athletes)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Untrained students (controls)
Number of subjects: 47
Study: 27181367

Group type: EXPERIMENTAL
Intervention: Oral Appliance (OA) therapy
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Baseline passive upper-airway collapsibility and loop gain
Number of subjects: 14
Study: 24418351

Group type: EXPERIMENTAL
Intervention: Restorative yoga
Number of subjects: 180

Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 180
Study: 22670258

Group type: EXPERIMENTAL
Intervention: Essential oil-containing mouthrinse (EO)
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride-containing mouthrinse (CPC)
Number of subjects: 408

Group type: COMPARATOR
Intervention: Negative control rinse
Number of subjects: 408
Study: 20181302

Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 to 40 mg per day plus IPT adapted to BPD (IPT-BPD)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Fluoxetine 20 to 40 mg per day plus clinical management
Number of subjects: 55
Study: 19060514

Group type: EXPERIMENTAL
Intervention: Intra-articular sodium hyaluronate injections (Orthovisc)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control group (only follow-up)
Number of subjects: 67
Study: 15951715

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 14616321

Group type: EXPERIMENTAL
Intervention: Inhalational anaesthesia (IA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA)
Number of subjects: 40
Study: 11119731

Group type: EXPERIMENTAL
Intervention: Oral HRT (2 mg of estradiol on days 1-12, 2 mg of estradiol plus 1 mg of norethisterone acetate on days 13-22, and 1 mg of estradiol on days 23-28; n = 21)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Transdermal HRT (50 microg/d of estradiol on days 1-28 and 250 microg/d of norethisterone acetate on days 15-28; n = 21)
Number of subjects: 42
Study: 9358693

Group type: EXPERIMENTAL
Intervention: CBT with respiratory training (CBT‐R)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: CBT without respiratory training (CBT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Delayed treatment (Control)
Number of subjects: 54
Study: 8237812

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3777162

Group type: EXPERIMENTAL
Intervention: [2‐3H]‐ and [6‐3H]glucose given simultaneously
Number of subjects: 8

Group type: COMPARATOR
Intervention: [3‐3H]glucose given
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Glucose infusion
Number of subjects: 8
Study: 29125933

Group type: EXPERIMENTAL
Intervention: Rigid fixation with 4 L miniplates placed bilaterally in the maxilla after distraction device removal.
Number of subjects: 22

Group type: COMPARATOR
Intervention: No miniplates placed after removing the distraction devices (control group).
Number of subjects: 22
Study: 28277060

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) with clopidogrel in addition to aspirin
Number of subjects: 165

Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 165
Study: 25516635

Group type: EXPERIMENTAL
Intervention: 3-weekly doses of nanoparticle albumin-bound paclitaxel
Number of subjects: 730

Group type: EXPERIMENTAL
Intervention: weekly doses of nanoparticle albumin-bound paclitaxel
Number of subjects: 730

Group type: COMPARATOR
Intervention: weekly doses of Cremophor-based paclitaxel
Number of subjects: 730
Study: 25945213

Group type: EXPERIMENTAL
Intervention: Tele-intervention (TI)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Traditional in-person home visits
Number of subjects: 27
Study: 21949754

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir monotherapy
Number of subjects: 83
Study: 18640467

Group type: EXPERIMENTAL
Intervention: Combination lidocaine 20 mg and dexamethasone 6 mg
Number of subjects: 140

Group type: COMPARATOR
Intervention: Lidocaine 20 mg
Number of subjects: 140

Group type: COMPARATOR
Intervention: Dexamethasone 6 mg
Number of subjects: 140
Study: 17031284

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 14526299

Group type: EXPERIMENTAL
Intervention: 400 microg of oral misoprostol every 8 hours
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 400 microg of vaginal misoprostol every 8 hours
Number of subjects: 43

Group type: COMPARATOR
Intervention: 400 microg vaginally every 12 hours (historic control)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Both groups (oral and vaginal misoprostol)
Number of subjects: 43
Study: 10651190

Group type: EXPERIMENTAL
Intervention: Topical lomefloxacin 0.3%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical ofloxacin 0.3%
Number of subjects: 40
Study: 8952750

Group type: EXPERIMENTAL
Intervention: DHEA treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 1751898

Group type: EXPERIMENTAL
Intervention: Lachman test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anterior drawer test
Number of subjects: 0

Group type: COMPARATOR
Intervention: KT1000 knee arthrometer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Jerk test
Number of subjects: 0
Study: 6802100

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate (20 mg) after pimozide pretreatment (5 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dextroamphetamine sulfate (20 mg) after placebo pretreatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate (20 mg) after pimozide pretreatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine sulfate (20 mg)
Number of subjects: 30
Study: 30507214

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) anger-reduction treatment for 12 weeks
Number of subjects: 158

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 158
Study: 29241450

Group type: EXPERIMENTAL
Intervention: Azacitidine
Number of subjects: 262

Group type: COMPARATOR
Intervention: Conventional care regimens (CCR)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Low-dose cytarabine
Number of subjects: 262
Study: 26409603

Group type: EXPERIMENTAL
Intervention: ERCP-first approach
Number of subjects: 257

Group type: COMPARATOR
Intervention: MRCP-first approach
Number of subjects: 257